Bal Pharma Limited
Share Price Target & Analysis
NSE:BALPHARMA
VWAP
Open
Close
High
Low
52 Week High
0.02 (0.02%)
BALPHARMA
(PHARMA)Sideways to Positive
52 Week Low
EPS
PE
PB
Deluxe
Quality
Steel
Valuation
#Analysis
NSE: BALPHARMA Share Price Financial Analysis & Valuation
Bal Pharma Limited (BALPHARMA) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of SME Stocks company with Market Capitalization of Rs 189.2 (in Cr). Total number of free float shares are 1.4 (in Lacs).
Bal Pharma Limited is listed on NSE with Exchange ID - INE083D01012 and trading code is NSE:BALPHARMA with short name Bal Pharma.
In the past 1 year, Bal Pharma Limited has declared an equity dividend of Rs 1.12 per share. At the current share price of BALPHARMA at Rs 107.44, this results in a dividend yield of 1.04 %.
As per the Fundamental Analysis of NSE:BALPHARMA, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine BALPHARMA underlying value and future prospects. All of this data is available in BALPHARMA financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:BALPHARMA, it is clearly understood that BALPHARMA is Deluxe performer in terms of earnings and profit margins with an EPS of 11.26. NSE:BALPHARMA book value per share as of today is 66.11. The current price to book ratio for BALPHARMA as of Sep 16, 2026 is 1.63.
Valuation of the Stock: The current valuation of BALPHARMA stock is like Steel which means currently the stock is Moderately Priced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of BALPHARMA whether to BUY this stock at current valuation. The delivery percentage of BALPHARMA is 123150% is very crucial parameter which shows that 123150% investors are anticipating that the price of BALPHARMA share should go up with VWAP at 111.04.
Now, the main question is whether to BUY or SELL, NSE:BALPHARMA at current valuation.
As per latest Analysis No. #1093:-
⇑ STRONG BUY BALPHARMA if All Greens
⇗ BUY BALPHARMA (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD BALPHARMA (With Stop Loss) if only 1 Green
⇘ SELL BALPHARMA if NO Green Indicator
NSE: BALPHARMA Share Price Today (Sep 16, 2026)
(Bal Pharma Limited Daily Analysis on the basis of BALPHARMA Intraday Graph & Trend)
Bal Pharma Limited share price moved Up by 0.02% from its previous close of Rs 107.42. BALPHARMA stock last traded price is 107.44. BALPHARMA share price trend is Up with a total of 107727 stocks traded till now. It has touched an intraday high of Rs 115 and an intraday low of Rs 107.07. The BALPHARMA trading at 107.44, Up by Rs. 0.02, or 0.02 percent which suggests that most of the Traders are anticipating that the price of BALPHARMA share should go Up.
NSE: BALPHARMA Share Price Tomorrow Prediction
(Bal Pharma Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of BALPHARMA)
Bal Pharma Limited share price moved Up by 0.02%. BALPHARMA share price short term trend is Up. It suggests that BALPHARMA Share Price for Tomorrow remains the same with VWAP at 111.04 will be treated as stop loss for intraday traders. Bal Pharma Limited Long term investors can follow the BALPHARMA long term trend as mentiond in future forecast table.
NSE Code |
NSE: BALPHARMA |
BALPHARMA Share Price Today |
107.44 |
BALPHARMA Share Price Target Prediction for 2026 ^ |
88.8 - 125.2 |
BALPHARMA Share Price Target Prediction for 2027*^ |
125.2 - 133.4 |
BALPHARMA Share Price Target Prediction for 2028*^ |
133.4 - 142.7 |
BALPHARMA Share Price Target Prediction for 2029*^ |
150 |
BALPHARMA Share Price Target Prediction for 2030*^ |
154 |
BALPHARMA Share Price Target Prediction for 2035*^ |
168 |
| BALPHARMA Current Book Value |
65.8 |
*Bal Pharma Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^BALPHARMA share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
BALPHARMA Technical Analysis
Candlestick Pattern: @114.45| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 95.59 | BUY | 98.75 | BUY |
| MA_12 | 89.07 | BUY | 92.01 | BUY |
| MA_20 | 88.04 | BUY | 90.2 | BUY |
| MA_32 | 88.21 | BUY | 88.58 | BUY |
| MA_50 | 86.67 | BUY | 87.42 | BUY |
| MA_100 | 85.72 | BUY | 85.19 | BUY |
| MA_200 | 78.46 | BUY | 83.89 | BUY |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 101.35 | OverBought |
| MACD | 2.35 | BUY |
| ADX | 24.26 | NO or Weak Trend |
| DMI (+/-) | 43.6 / 6.39 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 85.21 | Overbought |
| STOCHASTIC_K (Fast) | 97.65 | Overbought |
| STOCHASTIC_D (Slow) | 84.72 | Overbought |
| CCI | 313.63 | BUY |
| PSAR | 82.92 | BUY |
| TRUE RANGE | 19.35 | Neutral |
| ATR | 4.94 | BUY |
| WILLIAMS R | 0 | Overbought |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 100 | Overbought |
| STOCHASTIC RSI D | 100 | Overbought |
| MOMENTUM | 27.46 | BUY |
| Duration | Value |
|---|---|
| 1 Year | 31.98% |
| 3 Months | 30.37% |
| 1 Month | 31.57% |
| 1 Week | 33.63% |
| Action | Overall (%) |
|---|---|
| BUY | 90% |
| NEUTRAL / HOLD | 10% |
| SELL | 0% |
Most popular Questions & Answers about BALPHARMA (/ FAQ BALPHARMA)
Bal Pharma Limited stock last traded price is 107.44. BALPHARMA share price moved Up by 0.02% from its previous close of Rs 107.42.
Bal Pharma Limited share price trend is Up with a total of 107727 stocks traded till now. It has touched an intraday high of Rs 125.846 and an intraday low of Rs 107.07. The BALPHARMA trading at 107.44, Up by Rs. 0.02, or 0.02 percent which suggests that most of the Traders are anticipating that the price of BALPHARMA share should go Up and the Stop Loss will be around 111.04.
The market cap of Bal Pharma Limited is ₹189.2 (in Cr) as of Sep 15, 2026.
The current price to earning ratio for Bal Pharma Limited as of Sep 15, 2026 is 22.52.
The current price to book ratio for Bal Pharma Limited as of Sep 15, 2026 is 1.63.
The highest price of Bal Pharma Limited stock is ₹124.6 in the last 52-week.
The lowest price of Bal Pharma Limited stock is ₹60 in the last 52-week.
Bal Pharma Limited share trading at ₹107.44, Up by Rs. 0.02, or 0.02 percent which suggests that most of the traders are anticipating that the price of BALPHARMA share should go Up.
In 2026, Stock price target for Bal Pharma Limited (BALPHARMA) will be around ₹88.8 on downside and ₹125.2 on upside. Bal Pharma Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Bal Pharma Limited (BALPHARMA) will be around ₹125.2 on downside and ₹133.4 on upside. Bal Pharma Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Bal Pharma Limited (BALPHARMA) will be around ₹133.4 on downside and ₹142.7 on upside. Bal Pharma Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Bal Pharma Limited (BALPHARMA) will be around ₹154 Bal Pharma Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of BALPHARMA.
The price of Bal Pharma Limited (BALPHARMA) shares moved by 0.02%. The short-term trend for BALPHARMA share price is Up. It implies that the share price of BALPHARMA will stay the same tomorrow and that intraday traders should treat VWAP at 111.04 as a stop loss. Investors with a long-term outlook can track BALPHARMA long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of BALPHARMA stock is 135. Compared to the current market price of 107.44 INR, the BALPHARMA stock is Undervalued by 20.4%.
As per the fundamental analysis of Bal Pharma Limited (BALPHARMA), it is of Deluxe quality in terms of earnings and profit margins with an EPS of 11.26. Bal Pharma Limited book value per share as of today is 66.11. The current price to book ratio for BALPHARMA as of Sep 16, 2026 is 1.63.
NSE:BALPHARMA News & Other Useful Information about BALPHARMA Share Price
Peer Comparison of NSE: BALPHARMA
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1835.00 | 16.35 | 97.89 |
| DIVISLAB | 9198.00 | 115.55 | 663.06 |
| MEDICAMEQ | 318.20 | 12.15 | 208.08 |
| CIPLA | 1351.00 | 51.67 | 434.03 |
| DRREDDY | 1145.00 | 53.19 | 380.63 |
| TORNTPHARM | 4850.00 | 87.32 | 235.7 |
| BIOCON | 382.00 | 1.27 | 166.51 |
| LUPIN | 2063.20 | 154.86 | 718.37 |
| ALKEM | 5161.00 | 212.33 | 1218.48 |
| AUROPHARMA | 1660.00 | 46.49 | 403.84 |
| ABBOTINDIA | 26125.00 | 766.11 | 2448.41 |
| GLAXO | 2818.90 | 63.65 | 147.25 |
| IPCALAB | 1932.40 | 56.72 | 329.23 |
| LAURUSLABS | 1926.90 | 20.74 | 102.57 |
| LALPATHLAB | 1906.40 | 39.68 | 157.23 |
| PFIZER | 4041.60 | 170.54 | 963.41 |
| AJANTPHARM | 3510.40 | 89.3 | 363.23 |
| SANOFI | 3131.00 | 158.05 | 332.96 |
| NATCOPHARM | 819.15 | 82.14 | 481.67 |
| APLLTD | 824.75 | 48.4 | 295.69 |
| JBCHEPHARM | 2408.90 | 54.16 | 251.48 |
| GLENMARK | 2371.70 | 1.24 | 881.78 |
| AAREYDRUGS | 98.50 | 2.39 | 53.38 |
| JUBLPHARMA | 1011.95 | 4.35 | 145.63 |
| SPARC | 188.00 | 48.14 | 40.45 |
| GRANULES | 872.60 | 23.25 | 180.42 |
| ASTRAZEN | 6695.50 | 86.44 | 364.29 |
| CAPLIPOINT | 2570.60 | 55.52 | 285.6 |
| FDC | 349.70 | 21.19 | 161.21 |
| HIKAL | 212.22 | 9.34 | 96.63 |